1887

Abstract

Latency-associated nuclear antigen 1 (LANA1) of Kaposi's sarcoma-associated herpesvirus (KSHV) plays a pivotal role in the maintenance of the virus genome in latently infected cells. LANA1 links virus genomes to host chromosomes via a C-terminal DNA-binding domain which interacts with the sequences located in terminal repeats (TRs) of the virus genome and via an N-terminal chromosome-binding sequence which associates with the host chromosomes, respectively. Recent data suggest that LANA1 also actively participates in the replication of KSHV TR-containing plasmid in the transient DNA replication assay. In this report, it was found that C33A and COS-1, but not NIH/3T3, cell lines are permissive for the transient replication of KSHV TR-containing plasmid. Using several LANA1-deletion mutants, the minimum domain of LANA1 required for replication activity was also determined. In addition, the N terminus of LANA1 inhibited the transient replication systems of KSHV and Epstein–Barr virus (EBV) in transiently transfected 293 and 293T cells, but the C terminus of LANA1 specifically inhibited the transient replication system of KSHV in other cell lines. Consistent with previous reports, these data further emphasize the functional importance of the N terminus of LANA1 on replication from the KSHV latent origin of DNA replication.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19510-0
2004-04-01
2019-11-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/4/vir850843.html?itemId=/content/journal/jgv/10.1099/vir.0.19510-0&mimeType=html&fmt=ahah

References

  1. Almasan, A., Yin, Y., Kelly, R. E., Lee, E. Y., Bradley, A., Li, W., Bertino, J. R. & Wahl, G. M. ( 1995; ). Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci U S A 92, 5436–5440.[CrossRef]
    [Google Scholar]
  2. An, J., Lichtenstein, A. K., Brent, G. & Rettig, M. B. ( 2002; ). The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element. Blood 99, 649–654.[CrossRef]
    [Google Scholar]
  3. Ballestas, M. E. & Kaye, K. M. ( 2001; ). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J Virol 75, 3250–3258.[CrossRef]
    [Google Scholar]
  4. Ballestas, M. E., Chatis, P. A. & Kaye, K. M. ( 1999; ). Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641–644.[CrossRef]
    [Google Scholar]
  5. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W. & Knowles, D. M. ( 1995a; ). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332, 1186–1191.[CrossRef]
    [Google Scholar]
  6. Cesarman, E., Moore, P. S., Rao, P. H., Inghirami, G., Knowles, D. M. & Chang, Y. ( 1995b; ). In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86, 2708–2714.
    [Google Scholar]
  7. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M. & Moore, P. S. ( 1994; ). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865–1869.[CrossRef]
    [Google Scholar]
  8. Chaudhuri, B., Xu, H., Todorov, I., Dutta, A. & Yates, J. L. ( 2001; ). Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus. Proc Natl Acad Sci U S A 98, 10085–10089.[CrossRef]
    [Google Scholar]
  9. Chiang, C. M., Ustav, M., Stenlund, A., Ho, T. F., Broker, T. R. & Chow, L. T. ( 1992; ). Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci U S A 89, 5799–5803.[CrossRef]
    [Google Scholar]
  10. Cotter, M. A., II & Robertson, E. S. ( 1999; ). The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264, 254–264.[CrossRef]
    [Google Scholar]
  11. Cotter, M. A., II, Subramanian, C. & Robertson, E. S. ( 2001; ). The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus. Virology 291, 241–259.[CrossRef]
    [Google Scholar]
  12. Decker, L. L., Shankar, P., Khan, G., Freeman, R. B., Dezube, B. J., Lieberman, J. & Thorley-Lawson, D. A. ( 1996; ). The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 184, 283–288.[CrossRef]
    [Google Scholar]
  13. Del Vecchio, A. M., Romanczuk, H., Howley, P. M. & Baker, C. C. ( 1992; ). Transient replication of human papillomavirus DNAs. J Virol 66, 5949–5958.
    [Google Scholar]
  14. Demeret, C., Le Moal, M., Yaniv, M. & Thierry, F. ( 1995; ). Control of HPV 18 DNA replication by cellular and viral transcription factors. Nucleic Acids Res 23, 4777–4784.[CrossRef]
    [Google Scholar]
  15. Dhar, S. K., Yoshida, K., Machida, Y., Khaira, P., Chaudhuri, B., Wohlschlegel, J. A., Leffak, M., Yates, J. & Dutta, A. ( 2001; ). Replication from oriP of Epstein-Barr virus requires human ORC and is inhibited by geminin. Cell 106, 287–296.[CrossRef]
    [Google Scholar]
  16. Friborg, J., Jr, Kong, W., Hottiger, M. O. & Nabel, G. J. ( 1999; ). p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889–894.
    [Google Scholar]
  17. Garber, A. C., Shu, M. A., Hu, J. & Renne, R. ( 2001; ). DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75, 7882–7892.[CrossRef]
    [Google Scholar]
  18. Garber, A. C., Hu, J. & Renne, R. ( 2002; ). Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J Biol Chem 277, 27401–27411.[CrossRef]
    [Google Scholar]
  19. Groves, A. K., Cotter, M. A., Subramanian, C. & Robertson, E. S. ( 2001; ). The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters. J Virol 75, 9446–9457.[CrossRef]
    [Google Scholar]
  20. Gwack, Y., Hwang, S., Byun, H., Lim, C., Kim, J. W., Choi, E. J. & Choe, J. ( 2001; ). Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J Virol 75, 6245–6248.[CrossRef]
    [Google Scholar]
  21. Hirt, B. ( 1967; ). Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26, 365–369.[CrossRef]
    [Google Scholar]
  22. Hu, J., Garber, A. C. & Renne, R. ( 2002; ). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol 76, 11677–11687.[CrossRef]
    [Google Scholar]
  23. Hung, S. C., Kang, M. S. & Kieff, E. ( 2001; ). Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. Proc Natl Acad Sci U S A 98, 1865–1870.[CrossRef]
    [Google Scholar]
  24. Hwang, S. G., Lee, D., Kim, J., Seo, T. & Choe, J. ( 2002; ). Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner. J Biol Chem 277, 2923–2930.[CrossRef]
    [Google Scholar]
  25. Hyun, T. S., Subramanian, C., Cotter, M. A., II, Thomas, R. A. & Robertson, E. S. ( 2001; ). Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells. J Virol 75, 8761–8771.[CrossRef]
    [Google Scholar]
  26. Knight, J. S., Cotter, M. A., II & Robertson, E. S. ( 2001; ). The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter. J Biol Chem 276, 22971–22978.[CrossRef]
    [Google Scholar]
  27. Krithivas, A., Young, D. B., Liao, G., Greene, D. & Hayward, S. D. ( 2000; ). Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol 74, 9637–9645.[CrossRef]
    [Google Scholar]
  28. Krithivas, A., Fujimuro, M., Weidner, M., Young, D. B. & Hayward, S. D. ( 2002; ). Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J Virol 76, 11596–11604.[CrossRef]
    [Google Scholar]
  29. Lagunoff, M. & Ganem, D. ( 1997; ). The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology 236, 147–154.[CrossRef]
    [Google Scholar]
  30. Lee, D., Kim, H., Lee, Y. & Choe, J. ( 1997; ). Identification of sequence requirement for the origin of DNA replication in human papillomavirus type 18. Virus Res 52, 97–108.[CrossRef]
    [Google Scholar]
  31. Lim, C., Sohn, H., Gwack, Y. & Choe, J. ( 2000; ). Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. J Gen Virol 81, 2645–2652.
    [Google Scholar]
  32. Lim, C., Gwack, Y., Hwang, S., Kim, S. & Choe, J. ( 2001; ). The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem 276, 31016–31022.[CrossRef]
    [Google Scholar]
  33. Lim, C., Sohn, H., Lee, D., Gwack, Y. & Choe, J. ( 2002; ). Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J Virol 76, 10320–10331.[CrossRef]
    [Google Scholar]
  34. Lim, C., Lee, D., Seo, T., Choi, C. & Choe, J. ( 2003; ). Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. J Biol Chem 278, 7397–7405.[CrossRef]
    [Google Scholar]
  35. Lukac, D. M., Renne, R., Kirshner, J. R. & Ganem, D. ( 1998; ). Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252, 304–312.[CrossRef]
    [Google Scholar]
  36. Lukac, D. M., Kirshner, J. R. & Ganem, D. ( 1999; ). Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73, 9348–9361.
    [Google Scholar]
  37. Lupton, S. & Levine, A. J. ( 1985; ). Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Mol Cell Biol 5, 2533–2542.
    [Google Scholar]
  38. Middleton, T. & Sugden, B. ( 1994; ). Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J Virol 68, 4067–4071.
    [Google Scholar]
  39. Miller, G., Rigsby, M. O., Heston, L. & 7 other authors ( 1996; ). Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 334, 1292–1297.[CrossRef]
    [Google Scholar]
  40. Mizuguchi, H., Hosono, T. & Hayakawa, T. ( 2000; ). Long-term replication of Epstein-Barr virus-derived episomal vectors in the rodent cells. FEBS Lett 472, 173–178.[CrossRef]
    [Google Scholar]
  41. Moore, P. S., Gao, S. J., Dominguez, G. & 7 other authors ( 1996; ). Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol 70, 549–558.
    [Google Scholar]
  42. Piolot, T., Tramier, M., Coppey, M., Nicolas, J. C. & Marechal, V. ( 2001; ). Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J Virol 75, 3948–3959.[CrossRef]
    [Google Scholar]
  43. Qin, X. Q., Livingston, D. M., Kaelin, W. G., Jr & Adams, P. D. ( 1994; ). Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci U S A 91, 10918–10922.[CrossRef]
    [Google Scholar]
  44. Radkov, S. A., Kellam, P. & Boshoff, C. ( 2000; ). The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6, 1121–1127.[CrossRef]
    [Google Scholar]
  45. Rainbow, L., Platt, G. M., Simpson, G. R., Sarid, R., Gao, S. J., Stoiber, H., Herrington, C. S., Moore, P. S. & Schulz, T. F. ( 1997; ). The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71, 5915–5921.
    [Google Scholar]
  46. Reisman, D., Yates, J. & Sugden, B. ( 1985; ). A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Cell Biol 5, 1822–1832.
    [Google Scholar]
  47. Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D. & Ganem, D. ( 1996; ). Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2, 342–346.[CrossRef]
    [Google Scholar]
  48. Renne, R., Barry, C., Dittmer, D., Compitello, N., Brown, P. O. & Ganem, D. ( 2001; ). Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75, 458–468.[CrossRef]
    [Google Scholar]
  49. Russo, J. J., Bohenzky, R. A., Chien, M. C. & 8 other authors ( 1996; ). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93, 14862–14867.[CrossRef]
    [Google Scholar]
  50. Sarid, R., Flore, O., Bohenzky, R. A., Chang, Y. & Moore, P. S. ( 1998; ). Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 72, 1005–1012.
    [Google Scholar]
  51. Schepers, A., Ritzi, M., Bousset, K., Kremmer, E., Yates, J. L., Harwood, J., Diffley, J. F. & Hammerschmidt, W. ( 2001; ). Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus. EMBO J 20, 4588–4602.[CrossRef]
    [Google Scholar]
  52. Schwam, D. R., Luciano, R. L., Mahajan, S. S., Wong, L. & Wilson, A. C. ( 2000; ). Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. J Virol 74, 8532–8540.[CrossRef]
    [Google Scholar]
  53. Shan, B. & Lee, W. H. ( 1994; ). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 14, 8166–8173.
    [Google Scholar]
  54. Shinohara, H., Fukushi, M., Higuchi, M., Oie, M., Hoshi, O., Ushiki, T., Hayashi, J. & Fujii, M. ( 2002; ). Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1. J Virol 76, 12917–12924.[CrossRef]
    [Google Scholar]
  55. Soulier, J., Grollet, L., Oksenhendler, E. & 8 other authors ( 1995; ). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276–1280.
    [Google Scholar]
  56. Sun, R., Lin, S. F., Gradoville, L., Yuan, Y., Zhu, F. & Miller, G. ( 1998; ). A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95, 10866–10871.[CrossRef]
    [Google Scholar]
  57. Ustav, M. & Stenlund, A. ( 1991; ). Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J 10, 449–457.
    [Google Scholar]
  58. Wu, X. & Levine, A. J. ( 1994; ). p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci U S A 91, 3602–3606.[CrossRef]
    [Google Scholar]
  59. Yates, J. L., Warren, N. & Sugden, B. ( 1985; ). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812–815.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19510-0
Loading
/content/journal/jgv/10.1099/vir.0.19510-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error